GLP's
Cagrilintide
5 mg
Long-acting amylin analog
$50
Research overview
Cagrilintide is a long-acting amylin analog in clinical development for metabolic and weight-management research. Published trials and reviews evaluate amylin receptor biology, appetite pathways, and combination approaches with incretin therapies.
Potential research areas
- Amylin pathway research
- Appetite/satiety signaling
- Body-weight study endpoints
- Combination therapy research models
- Form
- Lyophilized Powder
- Category
- Research Peptide
- Use
- Research Only
Current evidence varies by compound. Many products discussed in this guide remain investigational, are not approved for general clinical use, and should only be handled under qualified research protocols.
No dosing, administration, or treatment instructions are provided.